PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.81
ESG score 90-95% of AFMD's 63.54. Bill Ackman would demand clear ESG improvement catalysts.
54.80
Environmental score 90-95% of AFMD's 60.48. Bill Ackman would demand clear environmental improvement catalysts.
57.90
Social score 80-90% of AFMD's 66.27. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.72
Similar governance score to AFMD's 63.86. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.